Arotinolol-d5 (hydrochloride)
Arotinolol-d5 (hydrochloride) is deuterium labeled Arotinolol. Arotinolol is a nonselective α/β-adrenergic receptor blocker and a vasodilating β-blocker[1][2][3]. Arotinolol also shows potency for inhibiting the binding of the radioligand 125I-ICYP to 5HT1B-serotonergic receptor sites. Arotinolol is an antihypertensive agent for the treatment of a variety of cardiovascular pathologies as well as non-cardiovascular diseases[1][2][3].
Product Specifications
CAS Number
2514848-16-7
UNSPSC
12352005
Target
5-HT Receptor; Adrenergic Receptor; Isotope-Labeled Compounds
Type
Reference compound
Related Pathways
GPCR/G Protein; Neuronal Signaling; Others
Applications
Neuroscience-Neuromodulation
Field of Research
Cardiovascular Disease
Smiles
O=C(C1=CC=C(S1)C2=CSC(SC([2H])(C([2H])(C([2H])(NC(C)(C)C)[2H])O)[2H])=N2)N.Cl
Molecular Formula
C15H17D5ClN3O2S3
Molecular Weight
413.03
References & Citations
Shipping Conditions
Room temperature
Scientific Category
Isotope-Labeled Compounds
Clinical Information
No Development Reported
Isoform
5-HT1 Receptor
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
CD106 / VCAM1 (B-K9), CF405S conjugate, 0.1mg/mL
CD106 / VCAM1 (B-K9), CF568 conjugate, 0.1mg/mL
CD44 Standard (DF1485), CF640R conjugate, 0.1mg/mL
